Source
From GlobeNewswire
27 releases originally issued via GlobeNewswire. The issuing organizations are responsible for their content.
Medline Inc.
Medline Inc. announces pricing of secondary offering of Class A common stock
Amesite Signs New 2,000-Patient NurseMagic® Enterprise Customer, Extending Growth Among Large Healthcare Organizations
Amesite announces its latest major enterprise win, increasing its revenue and deploying AI automations for another large healthcare organization in…
NETSOL Technologies reports fiscal first quarter 2027 revenue growth of 9.3% and gross margin expansion to 50.5%
First quarter revenue rises 9.3% to $16.4 million; GAAP net income of $0.16 million compared with a net loss in the prior-year period
Grace Therapeutics Announces Second Quarter 2027 Financial Results,
Provides Business Update
Power Solutions International Strengthens Longstanding HD Construction
Equipment Partnership with Multi-Year Engine Supply Commitment
NextNRG Enters into $7,000,000 Debt Exchange to Strengthen Stockholders’ Equity
Conversion of $7 Million in Debt and Accrued Obligations into Preferred Equity Supports Nasdaq Stockholders’ Equity Compliance Efforts
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
AirSculpt Technologies Reports Third Quarter Fiscal 2026 Results
Completes Term Loan Refinancing, Extending Maturity to 2031
Castellum Announces Third Quarter 2026 Financial Results
Ended the Quarter with a Debt-Free Balance Sheet and $24.5 Million of Cash and Accounts Receivable
Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2026
–Quarterly Revenue of $195.3 million –
BioCryst Reports Third Quarter 2026 Financial Results
Total net revenue of $180.3 million and ORLADEYO® net revenue of $174.8 million —
Ridgepost Capital Reports Third Quarter 2026 Financial Results
Taboola Reports Q3 2026 Financial Results;
Full Page Monetization Live Across All NBCUniversal; Fox News Live 100%;
Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion
COMPANY STRENGTHENS NEUROSCIENCE LEADERSHIP WITH WELTRUZA™ LAUNCH AND STRATEGIC ADDITION OF BXCL-501